2019 Novel Coronavirus-Important Information for Clinicians

JAMA. 2020 Mar 17;323(11):1039-1040. doi: 10.1001/jama.2020.1490.

Authors

Carlos Del Rio¹, Preeti N Malani^{2

3}

Affiliations

¹ Division of Infectious Diseases, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia.
² Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor.
³ Associate Editor.

PMID: 32022836
DOI: 10.1001/jama.2020.1490

No abstract available

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
COVID-19 Testing
China / epidemiology
Clinical Laboratory Techniques
Coronavirus Infections / diagnosis
Coronavirus Infections / drug therapy
Coronavirus Infections / epidemiology*
Humans
Pandemics
Pneumonia, Viral / diagnosis
Pneumonia, Viral / drug therapy
Pneumonia, Viral / epidemiology*
SARS-CoV-2

Substances

Angiotensin-Converting Enzyme Inhibitors
Anti-Inflammatory Agents, Non-Steroidal